Revenues

3 Months Ended

Mar. 31, 2022

Revenue from Contract with Customer [Abstract]

Revenues [Text Block]

11. Revenues

The following table presents our revenues disaggregated by revenue source.  Sales and usage-based taxes are excluded from revenues:

		March 31, 2022		March 31, 2021
Research and development agreements	$	225	$	126
Product revenue		-		160
Royalties on product sales		12		-
	$	237	$	286

The following table presents our revenues disaggregated by timing of recognition:

		March 31, 2022		March 31, 2021
(in U.S. $ thousands)
Product and services transferred at point in time	$	12	$	160
Products and services transferred over time		225		126
	$	237	$	286

The following table presents our revenues disaggregated by geography, based on the billing addresses of our customers:

		March 31, 2022		March 31, 2021
Europe	$	237		214
Canada		-		72
	$	237	$	286

Remaining performance obligations

As at March 31, 2022, the aggregate amount of the transaction price allocated to the remaining performance obligation is $1,803 representing research and development agreements, the majority of which is expected to be recognized in the next twelve months. The Company is also eligible to receive up to $2,559 in research and development milestone payments, approximately 100% of which is expected to be recognized in the next three years; up to $433 in commercial sales milestone payments which are wholly dependent on the marketing efforts of our development partners. In addition, the Company is entitled to receive royalties on potential sales.